Browse
Browse
Home
People
Organizations
Research
Events
Capability Map
UAB 1428 – A Phase II Randomized Controlled Trial of Genomically Directed Therapy After Preoperative Chemotherapy in Patients with Triple Negative Breast Cancer (HOG Trial)
Grant
Overview
Affiliation
Overview
Awarded By
HOOSIER CANCER RESEARCH NETWORK
Total Award Amount
0.00
Direct Costs
0.00
Sponsor Award Id
Affiliation
Contributor
Ahmed Elkhanany
Investigator
Erica Stringer-Reasor M.D.
Investigator
Lisle Nabell M.D.
Principal Investigator